Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jul 8.
Published in final edited form as: Structure. 2014 Jul 8;22(7):935–936. doi: 10.1016/j.str.2014.06.004

The HIV-1 Env trimer in HD

James B Munro 1, Walther Mothes 1
PMCID: PMC4094347  NIHMSID: NIHMS608855  PMID: 25007222

Abstract

Understanding the structure of the native HIV-1 envelope spike protein is critical for the development of vaccines and antiviral therapies. In this issue of Structure, Guttman and colleaguesuse Hydrogen/Deuterium(HD) exchangeto provide new insights into the structure of the HIV-1 Envtrimer and enhance our understanding how HIV-1 Env is activated for virus fusion.


The HIV-1 envelope (Env) spike protein mediates entry into cells. Since the Env trimer is the only viral protein on the surface of HIV-1, understanding its structure and activation by the CD4 receptor and coreceptor is vital for the design of vaccines and antiviral therapies. Due to itsheterogeneity, complex glycan shield, and conformational flexibility, the Env trimer has, until recently, eludedstructural characterization at high resolution. However, the last few months have seen an incredible advance in the understanding of the molecular structure of the HIV-1 Env trimer(Julien et al., 2013; Lyumkis et al., 2013). This breakthrough in structural characterization was possible thanks to the generation of soluble, cleaved HIV-1 Envtrimersby a team of researchers from Weill Cornell Medical College and The Scripps Research Institute(Binley et al., 2000; Ringe et al., 2013; Sanders et al., 2013). This is an example of howpersistence over a 15-year periodcan open the door to structural investigations that are of vital interestfor vaccine efforts against HIV-1/AIDS. This effort involved several key milestones: the generation of soluble Envtrimers that lack the hydrophobic transmembrane anchor and the membrane proximal extracellular region (MPER);identification ofthe clade-AHIV-1 isolate BG505 thatnaturally exhibits a more stable trimer; increasing trimer stability by introducing a disulfide bridge (referred to as SOS);optimizing the cleavage efficiency of the precursor into the mature trimer;and stabilizing the native ground state conformation by introducing a I559P mutation in the HR2 region (referred to as IP). This engineeringresulted in the cleaved BG505 SOSIP.664Env trimer. The antigenic features of the BG505 SOSIP.664 trimer indicate that it exhibits a near-native structure (Ringe et al., 2013; Sanders et al., 2013). Other widely usedsoluble trimers, from which the cleavage site has been removed, represent aberrant proteins that are not native trimers (Guttman and Lee, 2013; Ringe et al., 2013). The stability of the engineered BG505 SOSIP.664 Env trimer facilitated determination of its structure at ~5-Å resolution(Julien et al., 2013; Lyumkis et al., 2013), which has providedunprecedented insights into the spatial arrangements of HIV-1 Env, including how the variable V1/V2/V3 loops form the trimer association domain at the tip of the trimer, the gp120/gp41 interface, HR1 and HR2 helices in gp41, and peripheralglycans. Despite this major advance, the resolution is too low to thread the amino acid chain into the gp41 density. Moreover, the molecularunderstandingof how the trimer is activated by receptor CD4, and whether the trimer is conformationally dynamic, remains elusive.

In this issue, MiklosGuttman and colleagues use hydrogen/deuterium exchange (HDX) and oxidative labeling to address these open questions(Guttman et al., 2014). HDX is based on the exchange of hydrogen with the twice-as-heavy deuterium when the protein is switched fromnormalaqueous solvent (H2O)to deuterated solvent (D2O). Following the incubation in D2O, the protein is protealyticallydigested into small peptides, and the molecular mass of each peptideis determined by mass spec. Whereverhydrogen molecules were replaced with deuterium the mass of the peptide increases. HDX assists in characterizing the structure of the HIV-1 trimer by identifying accessible and poorly hydrogen-bonded regions of the timer. Conformational changes in response to ligands such as the receptor CD4 result in altered accessibility. Finally, the method alsoallows insights into conformational dynamics, or the “breathing” of the molecule. By incubating the protein in D2O for increasing periods of time, deuterium can reach areas of the trimer that are only rarely exposed. Applying HDX to the BG505 SOSIP.664, the authors confirm that the V1/V2/V3 regions have highly ordered segments, which is consistent with their role in trimer association (Julien et al., 2013; Lyumkis et al., 2013). TheN- and C-termini of gp120 that are entirely accessible in the monomeric gp120 are highly protected within the trimer. Thus, they are predicted to play an important role in the gp120/gp41 interaction. The authors then apply HDX to understand the structural changes in response to binding of receptor CD4. Naturally, the CD4-bindingsite becomes more protected upon interaction with CD4 (Figure 1). However, the V1/V2/V3 trimerization domain opens, exposing the V3 loop to allow coreceptor binding. CD4 also alters the gp41 subunit indicating that receptor binding primes the gp41 fusion machine. While for gp120 the CD4 mimetic NBD-556 causes structural changes similar to CD4, it doesnot have the same effect on gp41. Finally, with respect to conformational dynamics, the SOSIP.664 is indeed conformationally dynamic, and not locked in a closed ground-state conformation, as might have been suspected. Thus, this study adds to our emerging knowledge about the structure and dynamics of the HIV-1 Env trimer, and can guide the placement of the amino acid chain into the density of higher resolution structures. Ultimately, the structural aspects of this current study will likely soon be complemented by structures of sufficient resolution to depict gp41, and to characterize the structure of the CD4-bound conformation. However, HDX will continue to provide helpful insightsinto the dynamic nature of HIV-1 Env that other methods cannot easily access.

Figure 1. CD4-induced changes in the BG505 SOSIP.664 as determined by HDX(A).

Figure 1

Ground state structure (Julien et al., 2013; Lyumkis et al., 2013)fitted into the electron density map of (Liu et al., 2008): V1/V2 (yellow) and V3 (green), the bridging sheet (red), HR1 (purple) and gp120 inner domain (black). (B) Hypothetical CD4-bound structureof the trimer with the CD4-bound gp120 structure (Pancera et al., 2010)modeled into the electron density maps of (Liu et al., 2008)with CD4 shown in blue. Figures adapted from Guttman et al., 2014.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Binley JM, Sanders RW, Clas B, Schuelke N, Master A, Guo Y, Kajumo F, Anselma DJ, Maddon PJ, Olson WC, et al. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol. 2000;74:627–643. doi: 10.1128/jvi.74.2.627-643.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Guttman M, Garcia NG, Cupo A, Matsui T, Julien JP, Sanders RW, Wilson IA, Moore JP, Lee KK. CD4-induced activation in a soluble HIV-1 Env trimer. Structure. 2014 doi: 10.1016/j.str.2014.05.001. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Guttman M, Lee KK. A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140. J Virol. 2013;87:11462–11475. doi: 10.1128/JVI.01681-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse PJ, Burton DR, Sanders RW, Moore JP, et al. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science. 2013;342:1477–1483. doi: 10.1126/science.1245625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S. Molecular architecture of native HIV-1 gp120 trimers. Nature. 2008;455:109–113. doi: 10.1038/nature07159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lyumkis D, Julien JP, de Val N, Cupo A, Potter CS, Klasse PJ, Burton DR, Sanders RW, Moore JP, Carragher B, et al. Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science. 2013;342:1484–1490. doi: 10.1126/science.1245627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pancera M, Majeed S, Ban YE, Chen L, Huang CC, Kong L, Kwon YD, Stuckey J, Zhou T, Robinson JE, et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc Natl Acad Sci U S A. 2010;107:1166–1171. doi: 10.1073/pnas.0911004107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ringe RP, Sanders RW, Yasmeen A, Kim HJ, Lee JH, Cupo A, Korzun J, Derking R, van Montfort T, Julien JP, et al. Cleavage strongly influences whether soluble HIV- 1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A. 2013;110:18256–18261. doi: 10.1073/pnas.1314351110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sanders RW, Derking R, Cupo A, Julien JP, Yasmeen A, de Val N, Kim HJ, Blattner C, de la Peña AT, Korzun J, et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies. PLoS Pathog. 2013;9:e1003618. doi: 10.1371/journal.ppat.1003618. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES